Chris Schelling

Insider Reports History

Entity
Individual
Location
C/O Acer Therapeutics Inc., 222 Third Street, Cambridge, MA
Signature
/s/ Harry S. Palmin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chris Schelling:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acer Therapeutics Inc. PRESIDENT AND CEO, Director, 10%+ Owner Common Stock 2.71M $3.31M $1.22 Nov 29, 2022 Direct
Acer Therapeutics Inc. PRESIDENT AND CEO, Director, 10%+ Owner Common Stock, $0.0001 par value per share 0 Nov 17, 2023 Direct

Insider Reports Filed by Chris Schelling

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACER Acer Therapeutics Inc. Nov 17, 2023 1 $0 4 Nov 20, 2023 PRESIDENT AND CEO, Director, 10%+ Owner
ACER Acer Therapeutics Inc. Nov 29, 2022 1 $1M 4 Dec 1, 2022 President & CEO, Director, 10%+ Owner
ACER Acer Therapeutics Inc. Jan 14, 2022 1 $0 4 Jan 19, 2022 President & CEO, Director, 10%+ Owner